225 related articles for article (PubMed ID: 31358030)
1. Vitamin D receptor expression in invasive breast tumors and breast cancer survival.
Huss L; Butt ST; Borgquist S; Elebro K; Sandsveden M; Rosendahl A; Manjer J
Breast Cancer Res; 2019 Jul; 21(1):84. PubMed ID: 31358030
[TBL] [Abstract][Full Text] [Related]
2. Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis.
Al-Azhri J; Zhang Y; Bshara W; Zirpoli G; McCann SE; Khoury T; Morrison CD; Edge SB; Ambrosone CB; Yao S
Clin Cancer Res; 2017 Jan; 23(1):97-103. PubMed ID: 27407090
[TBL] [Abstract][Full Text] [Related]
3. Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality.
Zati Zehni A; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731733
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of vitamin D receptor in breast cancer: a systematic review and meta-analysis.
Xu H; Liu Z; Shi H; Wang C
BMC Cancer; 2020 Nov; 20(1):1051. PubMed ID: 33131491
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D Receptor in Breast Cancer Tissues and Its Relation to Estrogen Receptor Alpha (ER-α) Gene Expression and Serum 25-hydroxyvitamin D Levels in Egyptian Breast Cancer Patients: A Case-control Study.
Hemida MA; AbdElmoneim NA; Hewala TI; Rashad MM; Abdaallah S
Clin Breast Cancer; 2019 Jun; 19(3):e407-e414. PubMed ID: 30833174
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor (VDR) expression is not a prognostic factor in breast cancer.
Friedrich M; Villena-Heinsen C; Tilgen W; Schmidt W; Reichrat J; Axt-Fliedner R
Anticancer Res; 2002; 22(3):1919-24. PubMed ID: 12168894
[TBL] [Abstract][Full Text] [Related]
7. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
[TBL] [Abstract][Full Text] [Related]
8. Levels of Vitamin D and Expression of the Vitamin D Receptor in Relation to Breast Cancer Risk and Survival.
Huss L; Butt ST; Borgquist S; Elebro K; Sandsveden M; Manjer J; Rosendahl A
Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014861
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.
Heublein S; Mayr D; Meindl A; Kircher A; Jeschke U; Ditsch N
J Exp Clin Cancer Res; 2017 Apr; 36(1):57. PubMed ID: 28427429
[TBL] [Abstract][Full Text] [Related]
10. Alterations of Vitamin D Receptor (VDR) Expression Profile in Normal and Malignant Breast Tissues.
Zhalehjoo N; Shakiba Y; Panjehpour M
Clin Lab; 2016 Aug; 62(8):1461-1468. PubMed ID: 28164608
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D pathway related polymorphisms and vitamin D receptor expression in breast cancer.
Francis I; AlAbdali N; Kapila K; John B; Al-Temaimi RA
Int J Vitam Nutr Res; 2021 Jan; 91(1-2):124-132. PubMed ID: 31623531
[No Abstract] [Full Text] [Related]
12. Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein.
Ding P; Du X; Wan L; Zhao X; Zhang D; Huang Z; Cao G; Zhou X; Zheng Y; Cao Y
Oncol Res Treat; 2022; 45(4):166-177. PubMed ID: 34818655
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis.
Perna L; Butterbach K; Haug U; Schöttker B; Müller H; Arndt V; Holleczek B; Burwinkel B; Brenner H
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):437-42. PubMed ID: 23300018
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients.
Zhang X; Hofmann S; Rack B; Harbeck N; Jeschke U; Sixou S
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632174
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor expression and breast cancer mortality in a population-based prospective cohort.
Elebro K; Bendahl PO; Jernström H; Borgquist S
Breast Cancer Res Treat; 2017 Oct; 165(3):645-657. PubMed ID: 28643022
[TBL] [Abstract][Full Text] [Related]
16. Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.
Pulito C; Terrenato I; Di Benedetto A; Korita E; Goeman F; Sacconi A; Biagioni F; Blandino G; Strano S; Muti P; Mottolese M; Falvo E
PLoS One; 2015; 10(4):e0124894. PubMed ID: 25849303
[TBL] [Abstract][Full Text] [Related]
17. Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer.
Wang K; Dong M; Sheng W; Liu Q; Yu D; Dong Q; Li Q; Wang J
Histopathology; 2015 Sep; 67(3):386-97. PubMed ID: 25641222
[TBL] [Abstract][Full Text] [Related]
18. Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis: a prospective cohort study.
Lindgren H; Ademi D; Godina C; Tryggvadottir H; Isaksson K; Jernström H
Cancer Causes Control; 2024 Jun; 35(6):907-919. PubMed ID: 38351438
[TBL] [Abstract][Full Text] [Related]
19. The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014).
De Lara S; Nyqvist J; Werner Rönnerman E; Helou K; Kenne Sarenmalm E; Einbeigi Z; Karlsson P; Parris TZ; Kovács A
BMC Cancer; 2019 Feb; 19(1):187. PubMed ID: 30819139
[TBL] [Abstract][Full Text] [Related]
20. The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study.
Huss L; Gulz-Haake I; Nilsson E; Tryggvadottir H; Nilsson L; Nodin B; Jirström K; Isaksson K; Jernström H
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]